Genosity Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Genosity Inc. - overview
Established
2016
Location
-, NJ, US
Primary Industry
Biotechnology
About
Founded in 2016 and based in New Jersey, US, Genosity Inc. operates as a genomics company that offers various medical software solutions and various laboratory support and services. In April 2021, Invitae Corporation, a portfolio company of Thomas, McNerney & Partners, Genesys Capital Management, and many more, acquired Genosity Inc. , for USD 200 million.
As of 2023, the company is led by its president and Chief Technology Officer, Robert D. Daber. Genosity offers various next-generation sequencing (NGS) services that include data generation, basic research, clinical testing, whole exome sequencing (WES), trio exome sequencing, whole genome sequencing (WGS), tumor-normal genome sequencing, tumor profiling, DNA extraction, and many more. The company also provides medical software, Integrated Genomic Toolkit (IGT), used for various bioinformatics services, including tumor-normal analysis, longitudinal variant comparison analysis, proprietary capture, amplicon assay pipelines, and many more.
Current Investors
Genomic Health, Inc., Invitae Corporation
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Molecular Science, Genetics & Gene Therapy, Diagnostic, Medical & Imaging Laboratories, Pharmaceutical Research & Development, Medical Software
Website
www.genosity.com
Verticals
HealthTech
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.